General aspects of CV diseases. Clinical aspects of Heart Failure Flashcards

1
Q

What is the CV system comprised of?

A

Heart- pump and endocrine

Vessels- diameter and integrity

Blood- vol, viscosity, O2 carrying (PCV, Hgb, pH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What id CV insufficiency and what are the 2 main causes

A

CO is not sufficient enough to deliver the required amount of O2 to the tissues

  1. Heart failure (can lead to central shock)
  2. Periph circ failure= periph shock
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Periph circ failure: causes and compensatory mechanisms

A

Decreased BV and dilatoin of vessels!!

Acute compensatory reaction: symp alarm reaction- vasoC of non-vital organs, incr HR and contraction

Tre`tment: REPLACE blood vol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Heart failure:

A

primarily due to HD and secondary due to the cardiac changes (often induced by the HD)

  1. Phys and haemodynamic
  2. Neurohormonal
  3. Inflamm- cytokines and FR’s
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Phys/ haemodynamic aspects of HF

A

Preload

Afterload

Contractility

HR

Distensibility

Synch of beats (rhythm)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Frank-Sterling law

A

Preload!!

Incr length of myocytes– incr sensitivity of myofibrils to Ca– incr amount of Ca released for SR

The greater the venous return- the greater the contraction required to pump it

PAtho: overdilation- because the venous return is too high– congestion in venous system– at this point the cobtractility does not increase anymore.

The P in the LV will transfer to the L atrium– puml veins– pulm edema

P in RV– ascites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Leplace Law

A

Afterload (the P the heart must overcome to open Aorta and pump blood)

Incr in wall thicknedd to overcome an incr in P

Incr ejection P is caused by a decreased volume

Tension should be high (using O2 and E) during dilation of the wall, even if arterial P is normal

Training hypertrophy- does not induce increased wall stress

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Distensibility

A

Depends on the cardiac muscle itself e.g if there is hypertrophy OR if there is anything compressing the heart e.g fluid in the pericardium

Results: DECREASED left ventricular vol i.e diastolic filling i.e preload

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Preload

A

Stretch of myocytes

It increases

Leads to congestion and an increased O2 demand (is this because the myocytes are stretching more therefore require more O2??)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Afterload

A

Increases at beginning, the decreases.

Hypertrophy which requires more O2.. always detrimental

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Contractility

A

Increases!!

Higher O2 and E demand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

HR

A

Increases and then decr.

Correlates with SV because if there is more blood to be pumped then will beat faster. But if v high (above 180)- could mean that there is not enough time for diastolic filling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Distensibility

A

Increases!! is always patho- there is an increased O2 and E demand

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Rhythm

A

Decreases (sunch of heart beats)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Top priorities in compensation of HF

A

Sustain BP in vital organs (brain heart and kidneys)

Sustain BP in other organs

Keep preload low!!! i.e keep venous P low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Neurohormonal comp process (4)

A

Incr HR but decr diatolic filling and coronary flow

incr myocardial activity/contraction- leads to hypertrophy and incr O2 and E demands

Periph vasoC… but incr afterload

Incr blood vol- RAAS which incr preload, it is our third priority to keep this low– patho overcompensation (because the cells detect a decr in BP-salt and water reabs to incr circ vol, alsoc vasoC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Neural compensation

A

baroreceptors Detects decr in BP– Incr symp tone!!!!- if chronic baroreceptor stim then down reg of beta1 especially

Later AT2 also incr symp

+ ino, lsuio and chrono tropic

VasoC

Arrhythmias

Incr renin

Decr parasymp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

RAAS

A

Na and H2O reabs

K excretion

VasoC

Incr symp tone

Local: myocardial fibrosis, apoptosis and necrosis, hypertrophy

Cardiac remodelling (is this because of Aldosterone?)- ECM production

Arrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Progression of Cardiac failure (8)

A

permanent activation of RAAS

Incr HR

Incr O2 and E demand

Rhythmic disorders

FR’s

Inflamm mediators

Endotoxins to break down aldosterone e.g when there is liver failure

ET-1 release from endothel and myocard- receptors at endocardial layer and in valves— vasoC and hypertrophy

20
Q

Chronic HF- inflamm process, what causes fibrosis, necrosis and apoptosis?

A

AT 2

Aldosterone

Catecholamines

Endothelin

21
Q

What do the inflamm mediators IL 1.6 and TNF alpha do in chronic heart failure

A

Locally: necrosis and muscle damage

Systemically: cardiac cachexia, catab, alter carb digestion

Decr contractility

Hypertrophy, fibrosis

Incr synth of iNO (FR)

22
Q

Inflamm mediators thta are heroes and their role

A

Loss of Na and H20

VasoD

  1. ANF, BNF
  2. Bradykinin
  3. NO
  4. PG
23
Q

Inflamm mediators that are the villains and their role

A

VasoC

NA and H2O reabs

Cytotoxic

  1. AT2
  2. Aldosterone
  3. Endothelin
  4. IL-6
  5. TNF alpha
  6. Homocysteine
  7. Endotoxins
  8. FR’s
  9. NA
24
Q

What are responsible for cardiac remodelling?

A

ANS

RAAS

Inflamm mediators

25
Q

Macroscopic changes of cardiac remodelling

A

Concentric hypertrophy: muscle thickens but lumen is normal, P overload, seen with US

Eccentric hypertrophy: dilation of lumen, muscle may be thinner, vol overload

26
Q

Microscopic changes of cardiac remodelling

A

Apoptosis, necrosis, fibrosis

Cellular uncoupling

27
Q

Function/elctrophysio of cardiac remodelling

A

Ion channels and in communication

Incr number of receptors?

Ca mechanisms and therfore the contractility is altered- impacts systolic and diastolic function, maybe arryhtmias (both of which can be diagnosed with US)

28
Q

Heart disease and its relationship with circ failure

A

Failure is usually a result of severe heart disease, but can have heart disease without failure!

29
Q

5 major aspects of HF

A

Disfunction of myocard

Failed pump action

Failed. diastolic distension

Brady, tachycard and arryhthmias

Hyperkinetic

30
Q

Causes of failed pump (sytolic, mechanical) action of the heart

A

P overload- stenosis

Vol overload: valves disoreder, infusion OD, periph ateriovenous shunt

31
Q

Causes of hyperkinetic (this is v high out[ut circ)

A

Gravidity

Fever

Anaemia

Hyperthyroidism- v high HR in cats

32
Q

Left-sided heart failure

A

pulm edema

Cats only: acc of modified transufate/chylous in the thorax

Congestion is BEHIND the L side: goes from ventricles- atria- pulm veins— in lungs hydrostatic P> oncotic P— pulm edema– dyspnoea and the suffocation!

33
Q

Signd of L sided HF

A

Tachypnoea

Mixed dyspnoea

Pulm edema- progressive cough

Pleural fluid in cats

Cerebral hypoxia- Adam Stokes breathing

Prerenal azotemia

34
Q

R Sided HF *rare in cats*

A

Ascites ALWAYS!!

+/- pleural/pericard fluid

Modified transudate, chylous

SC fluid

Heptatomegaly

35
Q

Signs of R sided HF

A

Distension of jugular vein- + reflux test

Congested abd organs (liver)

ASCITEs

pleural fluid

36
Q

Main diseases causing HF in cats and dogs

A

Dogs: ENDOCARDOSIS/ mitral valve disease, then cardiomyopathy

In cats number 1 is cardiomyopathy

37
Q

ACVIM staging of heart failure

A

A) High risk but no identifiable structural disorder

B1) Asymptomatic with no evidence of remodelling

B2) Asymptomatic WITH cardiac remodelling

*note in B they have the disease but not failure*

C) Past/current clinical signs of HF associated with structural HD

D)Have end-stage disease and clinical signs of HF- refractory to the standard therapy

38
Q

Treatment of HF: decreasing the preload i.e the venous return

A

Diuretics

VenoD’s- nitrates, PIMOBENDAN

39
Q

Treatment of HF: Decreasing afterload

A

Only for category D!! because would cause hypotension so only use in refractory cases!!

Arterial Dilators: Amlodipine and Hydralazine

VenoD - PIMOBENDAN!

40
Q

Treatment of HF: Increasing contractility

A

Calcium sensitizers: Digoxin and pimobendan

41
Q

Digoxin

A

Inhibits the Na/K pump

Be careful as is proarrhyth!! because in small doses has beta adrenergic stim and causes hypokalaemia

Maintains baroreceptor function and decr adren overlaod

Narrow TI

Is used to treat supraventric arrhythmias

42
Q

Pimobendan

A

Calcium sensitizer, PDE inhib, veino and vasoD, relaxation

Indications:

  • ALWAYS CHF!!
  • DCM preclinical state
  • MMVD preclinical stae if heart dialted

Give PO or IV

43
Q

Treating CHF in an emergency

A

Must confirm the diagnosis!!

O2

Decr preload: IV diuretics, pimobedan

Decr afterload

Incr contractility: pimobendan, dobutamine

Sedate: ACP or but

Treat life-threatening arrhythmias

44
Q

Treating a chronic CHF case

A

Furosemide (smallest effective dose)

Pimobendan

Prevent the neuroendocrine overcomp ( byt the RAS aldosterone escape?) ACE-1, spironolactone

Supplement K and B-vits

Decr HR: beta or Ca channel blockers

Treat ventric arryhtmias: sotalol or amiodarone

45
Q

Treating CHF severe refractory case

A

All as for chronic CHF +++

Restrict salt

Give diuretics parenterally! and use a combo

Incr Pimobedan

Amlodipine

Sildenafil- for pulm hyperT

Hydralazin (small dosage)